Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06206239 · ClinicalTrials.gov registry record
Evaluation of Barriers to Cancer Care Delivery and Outcomes for Women of Color With Metastatic Breast Cancer
A clinical trial, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- 44
- Enrollment target
NCT06206239 is a clinical trial that has completed, run by Thomas Jefferson University. The registered enrollment target is 44 participants.
The verdict
NCT06206239 has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- 44 participants
- Enrollment target
Study Summary
This study evaluates disparities and barriers in cancer care delivery and outcomes in women of color by identifying socioeconomic variables that may be related to the inequity. Social determinants of health, or the conditions in which people live, work, and play, have a profound effect on health outcomes. This research is being done to understand whether social determinants of health factors like employment, household income, and home ownership affect access to care services and outcomes for patients with metastatic breast cancer who receive their cancer treatment at Sidney Kimmel Cancer Center at Jefferson Health.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2022-03-09 |
| Est. Completion | 2024-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06206239
The ClinicalTrials.gov registry entry for NCT06206239 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT06206239 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06206239 about?
NCT06206239 is a clinical study titled "Evaluation of Barriers to Cancer Care Delivery and Outcomes for Women of Color With Metastatic Breast Cancer". This study evaluates disparities and barriers in cancer care delivery and outcomes in women of color by identifying socioeconomic variables that may be related to the inequity. Social determinants of health, or the conditions in which people live, work, and play, have a profound effect on health out...
What is the current status of trial NCT06206239?
This trial is currently completed. The enrollment target is 44 participants. The study started on 2022-03-09. Estimated completion is 2024-03-31.
Who is sponsoring clinical trial NCT06206239?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.